Lowest neonatal serum sodium predicts sodium intake in low birth weight children

Adi Shirazki1, Zalman Weintraub, Dan Reich

  • 1Department of Psychology, University of Haifa, Haifa, Israel 31905.

Insights

Low birth weight children with lower neonatal serum sodium levels show increased dietary sodium intake later in life. Perinatal sodium loss significantly impacts long-term sodium consumption in these children.

Area of Science:

  • Pediatrics
  • Nutrition Science
  • Neonatology

Background:

  • Low birth weight (LBW) is associated with various long-term health challenges.
  • Neonatal factors may influence later-life dietary preferences and habits.
  • Understanding factors affecting sodium intake is crucial for managing cardiovascular health.

Purpose of the Study:

  • To investigate the long-term relationship between neonatal factors and salt appetite in low birth weight children.
  • To determine if neonatal diuretic treatment or lowest serum sodium level (NLS) predicts later dietary sodium intake.

Main Methods:

  • Forty-one low birth weight children (aged 8-15 years) were assessed.
  • Evaluations included salt and sweet preference tests, snack intake, and dietary questionnaires.
  • Neonatal records, including lowest serum sodium level (NLS), were analyzed.

Main Results:

  • Sodium appetite was not linked to neonatal diuretic treatment, birth weight, or gestational age.
  • A significant inverse correlation was found between reported dietary sodium intake and neonatal NLS (r = -0.445, P < 0.005).
  • This relationship was consistent across genders and ethnicities.

Conclusions:

  • Low neonatal serum sodium levels predict increased dietary sodium intake in low birth weight children.
  • Perinatal sodium loss, regardless of cause, is a significant contributor to long-term sodium intake.
  • Early life sodium balance may have lasting effects on dietary habits.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...